Last week I watched the "Lab to Market Pitch Competition" in Athens, this was the inaugural Greece cohort of a programme run by Columbia University, National Technical University of Athens, Endeavor and Hellenic Institute of Advanced Studies, with teams competing for a €50,000 prize pool in front of judges from Boston Consulting Group, the Bank of Greece and several VC funds.
Europe's research-to-commercialisation gap is well documented at this point. European universities produce roughly twice the scientific publishing output of the US, yet Europe accounts for only around 25% of new biotechs and less than 10% of deep tech unicorns. Deep tech made up 44% of European VC funding in 2023, but only 23% of university spin-offs actually operate in deep tech, versus over 60% in the US. The research is there. Too much of it still gets lost in what people in this space call "the valley of death", that’s the gap between a lab result and a company.
I've read some of the latest think pieces diagnosing that gap. What I found interesting watching this programme in action was that it's already doing something practical about it and the model is worth understanding, whether or not you ever go through a formal programme like it.
What the model actually does differently
These teams didn't just get a stage. They got months of structured training and mentorship, plus a week-long immersion in New York's innovation ecosystem, before they ever pitched. That sequence matters. It's not "build something, then figure out how to sell it." It's commercial thinking built in alongside the technical work, from early on, with people who've done this before checking the thinking as it develops.
That's the piece most research-led founders don't get by default. A brilliant technical result and a fundable venture are not the same thing, and very few PhD or research programmes teach the second one. Programmes like this exist precisely to close that specific gap; not funding, not talent, but the translation between the two.
What you can do without a formal programme
Most research-led founders won't have access to something this structured. Here's what the same underlying discipline looks like if you're building this on your own:
1. Find someone who can do the translation work early.
That’s someone who's done this before and can help turn a technical result into a commercial narrative: what problem this solves, for whom, why now, and how to actually reach and win those first buyers. That's a distinct skill from the science itself, and a different one again from fundraising. It's about shaping the go-to-market and sales story that gets real clients in the door, whether the venture ends up VC-backed or self-funded. Those early paying "logos" often end up being the strongest proof of concept a founder can put in front of an investor later, but the work itself is about winning the client, not the cheque. The teams who benefit most from programmes like Lab to Market aren't smarter than everyone else. They just get that translation, and the honest commercial feedback that comes with it, months earlier than founders working alone.
Most research-led founders can't pay for this yet, and they don't need to. This kind of support usually exists to be found rather than bought. It shows up in industry meetups, founder communities, LinkedIn conversations with commercial experts or simply asking a former colleague now working commercially for an honest hour of their time. The paid, dedicated version tends to matter later, once you have early traction and want to scale client acquisition properly. This version will lead to sustainable revenue and brand growth. Before that point, the job isn't to hire this skill. It's to find it wherever it's already on offer.
2. Practise explaining your research to someone outside your field, regularly.
Find the version of the story that a buyer, not a peer reviewer, actually needs to hear. This is a skill, and like any skill it only improves with repetition and real feedback, not with more time spent perfecting the technical work alone.
3. Go looking for the room, don't wait for it to find you.
Structured programmes are wonderful when you can access them, but they're a small fraction of what's available. Pitch competitions, accelerator open calls, university tech transfer offices, sector-specific investor events; the commercial rooms exist. Most research-led founders simply don't walk into them early enough.
4. Treat commercial validation as part of the research, not a distraction from it.
The founders who eventually raise or generate revenue aren't the ones who finished the technology and then thought about the market. They're the ones who let early market feedback shape the technology decisions along the way.
The bigger picture
Europe's funding gap is real, and policy conversations about it matter. But sitting in that room in Athens, watching talented researchers learn to translate what they'd built into something investable, was a reminder that some of the bridge across that gap doesn't need to wait for policy. It needs more of exactly what I watched happen, that’s structured commercial mentorship, early and consistently, for people whose instinct is rightly to go deep on the science first.
If you're building something research-led right now, the practical takeaway isn't "wait for Europe to fund you better." It's "find your version of this room", so you can get there faster.
Key sources referenced:
Columbia Global Centers, "Lab to Market Pitch Competition 2026" — event details, prize pool, judges
"McKinsey & Company, "Can European biotechs achieve greater scale in a fragmented landscape?" — Europe's scientific publishing output vs the US and China" , June 2021
Stryber, "Deep Tech commercialization in Europe: The gap, the challenge, and the fix", March 2025
CEPR, "The venture capital challenge for Europe", February 2026
European Commission, "Spin-offs: Driving innovation across the EU-27", February 2025
PostQuantum, "Deep-Tech Commercialization Challenges in the EU", May 2025
Istituto Affari Internazionali, "Bridging the EU's Innovation Gap: Supporting Hubs for Academic-Powered Enterprises", July 2025